Prolong Pharmaceuticals Is A Clinical Stage Biopharmaceutical Company Dedicated To Developing Innovative Therapies For Complex Diseases With Unmet Medical Needsthe Company Specializes In Central Nervous Systemhematologyand Respiratory Disordersutilizing Proprietary Drug Delivery Technologies To Enhance Its Therapeutic Pipeline Prolong Is Known For Its Expertise In Pegylationa Technology That Improves Protein Stability And Functionalityits Proprietary Pegfinity Process Allows For Rapid Lead Generation And Optimization Of Protein Therapeuticsone Of Its Key Products In Development Is Pp 007Sanguinateaa Pegylated Gas Transfer Agent Aimed At Restoring Homeostasis In Conditions Like Stroke And Sickle Cell Diseasethe Company Also Targets Cystic Fibrosis Among Other Conditions Led By A Team Of Industry Veteransprolong Collaborates With Clinical Advisors From Prestigious Institutionsfocusing On Stroke Related Therapeuticsas A Clinical Stage Companyit Engages With Clinical Trial Participants And Healthcare Providerspositioning Itself For Future Advancements In The Biopharmaceutical Market
No conferences found for this company.
| Company Name | Prolong Pharmaceuticals Llc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
